Brought to you by 
Pharmasset closes $40mm Series D round
19 Mar 2013
Executive Summary
Drug discovery company Pharmasset (cancer and antiviral therapeutics) raised $40mm through a Series D private placement led by Burrill & Co. New investor MDS Capital, which contributed significantly, and CDIB BioScience Ventures were joined by returning shareholders MPM Capital and Techno Venture Management.
Deal Industry
- Pharmaceuticals
-
Biotechnology
- Drug Discovery Tools
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Pharmasset closes $40mm Series D round
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice